Average Co-Inventor Count = 2.59
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoechst Aktiengesellschaft (24 from 6,662 patents)
2. Aventis Pharma Deutschland, Gmbh (3 from 330 patents)
3. Aventis Research & Technologies Gmbh & Co Kg (3 from 57 patents)
4. Sanofi-a Ventis Deutschland Gmbh (2 from 1,829 patents)
5. Roussel Uclaf (2 from 854 patents)
6. Hoechst Roussel Pharmaceuticals (1 from 539 patents)
7. Hoeschst Aktiengesellschaft (1 from 15 patents)
8. Hoechst Aktiengesllschaft (1 from 3 patents)
9. Hoechst Aktienegesellschaft (1 from 1 patent)
37 patents:
1. 7402601 - Pharmaceuticals for the treatment of rejection reactions in organ transplantations
2. 7071222 - Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
3. 6545006 - Process for obtaining L-dihydroorotic acid and use thereof
4. 6403299 - DEAH-box proteins
5. 6288098 - Pharmaceuticals for the treatment of rejection reactions in organ transplantations
6. 6251645 - DEAH-box proteins
7. 6159988 - Arylcycloalkyl derivatives, their production and their use
8. 6133301 - Pharmaceuticals for the treatment of rejection reactions in organ
9. 5942429 - DEAH-box proteins
10. 5814627 - 3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and
11. 5780592 - Compositions comprising lipoproteins and crotonamide derivatives
12. 5776977 - Arylcycloalkyl derivatives, their production and their use
13. 5773470 - Medicinal use of n-phenyl-2-cyano-3-hydroxycrotonamide derivatives
14. 5747664 - N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives
15. 5728721 - Pharmaceuticals for the treatment of rejection reactions in organ